#TSP TruSpine Technologies PLC – Result of 2025 AGM December 10, 2025 – Posted in: TruSpine Plc (TSP)

TSP Advanced Technologies plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that at its 2025 AGM held earlier today all resolutions were duly passed. Details of the votes received will be available shortly on the Company’s website. The Directors of the Company are responsible for the release of this announcement. -END- TSP Investor Hub https://truspinetech.com/aqse-rule-4-14 TSP Advanced Technologies plc Tel: +44 (0)20 7118 0852 Geoff Miller, Non-executive Chairman Cairn…

#TSP TruSpine Technologies PLC – Final Results September 30, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems, reports its full year results for the year ended 29 March 2024. The Company continues to be in a pre-revenue development phase and remains loss making at this stage of its development. The loss before taxation for the year was £702k (2023: £853k) after administrative expenses of £656k (2023: £846k). The R&D tax…

#TSP TruSpine Technologies PLC – AGM Statement & Change of Website June 7, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, is pleased to announce that at the Company’s 2023 Annual General Meeting (“AGM”) to be held later today, Chairman Geoff Miller will make the following statement: “In the three months since the appointment of three new Directors, the Board restructuring and the 2022 AGM, I am pleased to be able to report that we have made significant progress in refocussing…

#TSP Truspine Technologies PLC – Notice of 2023 AGM May 10, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that notice of the Company’s 2023 annual general meeting (“2023 AGM”) will be sent to shareholders shortly. The 2023 AGM will be held at the offices of Hill Dickinson LLP at The Broadgate Tower, 20 Primrose Street, London, EC2A 2EW on 7 June 2024 at 11:30 am. A copy of the notice of the 2023 AGM, along with…

#TSP Truspine Technologies PLC – Convertible Loan, Loan Update, AGM Update and RPT February 14, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has entered into a £50,000 convertible loan note agreement with Martin Armstrong (the “CLN Agreement”), the former Non-Executive Chairman of the Company. The Company also provides an update on the loan agreement announced on 5 January 2024 and on its 2022 annual general meeting (“2022 AGM”) which is due to be convened. CLN Agreement Pursuant to the…

#TSP TruSpine Technologies PLC – IP Registration October 25, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems announces that it has, with the help of the Company’s newly appointed IP lawyers, published the original assignment of the Intellectual Property Rights to the Company as per the Original IP Agreement and Addendum. The patents acquired as part of the Intellectual Property Rights can be viewed at the following link: https://assignment.uspto.gov/patent/index.html#/patent/search/resultAssignee?assigneeName=TRUSPINE%20TECHNOLOGIES%20LIMITED Capitalised terms…

#TSP TruSpine Technologies PLC – Final Results September 29, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems, reports its full year results for the year ended 29 March 2023. The Company continues to be in a pre-revenue development phase and remains loss making at this stage of its development. The loss before taxation for the year was £853k (2022: £941k) after administrative expenses of £846k (2022: £938k). The R&D tax…

TruSpine Technologies #TRU – Loan repayment & Update June 28, 2023 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, further to the announcement on 25 April 2023, the Company has repaid the £100,000 loan and accrued interest under the Loan Agreement with Annabel Schild. The Funding Loan was repaid from existing cash resources following receipt of a HMRC R&D tax credit of approximately £200,000 (“Tax Credit”). Update on Working Capital The Company has limited…

#VELA investee co. #TSP TruSpine Technologies PLC – Update re Loan May 9, 2023 – Posted in: TruSpine Plc (TSP), Vela Technologies Plc (VELA)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces an update to the announcement released by the Company on 28 February 2023 in relation to the Loan Agreement entered into by the Company. The announcement of 28 February 2023 omitted to disclose a fixed and floating charge over the Company’s intellectual property to the lender as security for the proceeds of which were received on 27 February 2023.…

#TSP TruSpine Technologies PLC – Shareholder Requisition Notice April 26, 2023 – Posted in: Uncategorized

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has received an email dated 14 April 2023 from Janice Stone, Peter Houghton, Todd Michael Cramer and Christopher Blank (together the “Named Shareholders”), who hold in excess of 5 per cent. of the issued share capital of the Company, requiring that the Company convene, as soon as reasonably practicable, a general meeting (“Requisition”). The board changes proposed…